KO vs ZYME · P/E 25, rev $47.94B vs rev $76.3M
The Coca-Cola Company (KO) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
KO currently screens at market cap $343.90B and trailing P/E 25.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the KO and ZYME stock pages for the full models.
Not investment advice.